RU2006134154A - METHOD FOR THERAPY OF INDIVIDUAL DISORDERS IN THE BLOOD SYSTEM UNDER EXPERIMENTAL NEUROTIC INFLUENCES - Google Patents
METHOD FOR THERAPY OF INDIVIDUAL DISORDERS IN THE BLOOD SYSTEM UNDER EXPERIMENTAL NEUROTIC INFLUENCES Download PDFInfo
- Publication number
- RU2006134154A RU2006134154A RU2006134154/14A RU2006134154A RU2006134154A RU 2006134154 A RU2006134154 A RU 2006134154A RU 2006134154/14 A RU2006134154/14 A RU 2006134154/14A RU 2006134154 A RU2006134154 A RU 2006134154A RU 2006134154 A RU2006134154 A RU 2006134154A
- Authority
- RU
- Russia
- Prior art keywords
- neurotic
- influences
- blood system
- therapy
- system under
- Prior art date
Links
- 239000008280 blood Substances 0.000 title claims abstract 3
- 210000004369 blood Anatomy 0.000 title claims abstract 3
- 238000000034 method Methods 0.000 title claims abstract 3
- 238000002560 therapeutic procedure Methods 0.000 title 1
- DNXIKVLOVZVMQF-UHFFFAOYSA-N (3beta,16beta,17alpha,18beta,20alpha)-17-hydroxy-11-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-yohimban-16-carboxylic acid, methyl ester Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(C(=O)OC)C(O)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 DNXIKVLOVZVMQF-UHFFFAOYSA-N 0.000 claims abstract 2
- 241000699670 Mus sp. Species 0.000 claims abstract 2
- LCQMZZCPPSWADO-UHFFFAOYSA-N Reserpilin Natural products COC(=O)C1COCC2CN3CCc4c([nH]c5cc(OC)c(OC)cc45)C3CC12 LCQMZZCPPSWADO-UHFFFAOYSA-N 0.000 claims abstract 2
- QEVHRUUCFGRFIF-SFWBKIHZSA-N Reserpine Natural products O=C(OC)[C@@H]1[C@H](OC)[C@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)C[C@H]2[C@@H]1C[C@H]1N(C2)CCc2c3c([nH]c12)cc(OC)cc3 QEVHRUUCFGRFIF-SFWBKIHZSA-N 0.000 claims abstract 2
- 239000000219 Sympatholytic Substances 0.000 claims abstract 2
- 229940079593 drug Drugs 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims abstract 2
- 230000000694 effects Effects 0.000 claims abstract 2
- BJOIZNZVOZKDIG-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C([C]5C=CC(OC)=CC5=N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 BJOIZNZVOZKDIG-MDEJGZGSSA-N 0.000 claims abstract 2
- 229960003147 reserpine Drugs 0.000 claims abstract 2
- MDMGHDFNKNZPAU-UHFFFAOYSA-N roserpine Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(OC(C)=O)C(OC)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 MDMGHDFNKNZPAU-UHFFFAOYSA-N 0.000 claims abstract 2
- 230000000948 sympatholitic effect Effects 0.000 claims abstract 2
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Способ терапии индивидуальных нарушений в системе крови при экспериментальных невротических воздействиях путем введения однократно внутрибрюшинно за 5 мин до невротического воздействия симпатолитика резерпина, отличающийся тем, что данный препарат вводят в дозе 1 мг/кг хорошо обучаемым мышам и в дозе 2 мг/кг плохо обучаемым.A method for treating individual disorders in the blood system during experimental neurotic influences by administering once intraperitoneally 5 minutes before the neurotic effect of reserpine sympatholytic, characterized in that this drug is administered at a dose of 1 mg / kg to well-trained mice and at a dose of 2 mg / kg to poorly trained.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2006134154/14A RU2329806C2 (en) | 2006-09-25 | 2006-09-25 | Method of blood system disturbance therapy associated with experimental neurotic affects |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2006134154/14A RU2329806C2 (en) | 2006-09-25 | 2006-09-25 | Method of blood system disturbance therapy associated with experimental neurotic affects |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2006134154A true RU2006134154A (en) | 2008-03-27 |
| RU2329806C2 RU2329806C2 (en) | 2008-07-27 |
Family
ID=39811201
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2006134154/14A RU2329806C2 (en) | 2006-09-25 | 2006-09-25 | Method of blood system disturbance therapy associated with experimental neurotic affects |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2329806C2 (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2061475C1 (en) * | 1992-12-18 | 1996-06-10 | Научно-исследовательский институт фармакологии Томского научного центра РАМН | Medicinal agent stimulating erythroide hemopoiesis germ at cytostatic myelodepression states |
| RU2240604C1 (en) * | 2003-02-27 | 2004-11-20 | Научно-исследовательский институт фармакологии Томского научного центра Российской академии медицинских наук | Method for modeling posthypoxic encephalopathy and encephalopathy-associated disorders in blood system |
-
2006
- 2006-09-25 RU RU2006134154/14A patent/RU2329806C2/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2329806C2 (en) | 2008-07-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2006102596A3 (en) | Dosage regimen for the treatment of a traumatic brain injury with progesterone | |
| WO2008039898A3 (en) | Methods for the treatment of a traumatic central nervous system injury | |
| EA201270144A1 (en) | COMBINED THERAPY FOR TREATMENT OF DIABETES | |
| EA201791669A2 (en) | NEW THERAPEUTIC APPROACHES IN THE TREATMENT OF SMT AND RELATED DISORDERS | |
| CO6150188A2 (en) | USE OF TEENCTEPLASA TO TREAT AN ACUTE ISCHEMICAL ICTUS | |
| ZA200802811B (en) | Therapy for the treatment of disease | |
| MY153062A (en) | Methods of treating gastrointestinal disorders independent of the intake of food | |
| UA105644C2 (en) | Methods of treating pulmonary disorders with liposomal amikacin formulations | |
| RU2014150942A (en) | TREATMENT OF SIDE EFFECTS IN THE FORM OF MOTOR AND MOTOR DISORDERS RELATED TO THE TREATMENT OF PARKINSON'S DISEASE | |
| MX2009003532A (en) | Treatment of infant hyperbilirubinemia using low dosages of stannsoporfin. | |
| PH12019502651A1 (en) | Use of vibegron to treat overactive bladder | |
| EA200800075A1 (en) | DOSING CIRCUIT FOR WISE | |
| WO2009003694A3 (en) | Method for treating diseases related to mitochondrial dysfunction | |
| EA200970127A1 (en) | MODULATOR OF GLUCOCORTICOSTEROID RECEPTORS AND METHODS OF ITS APPLICATION | |
| ATE405272T1 (en) | TREATMENT OF T-CELL LYMPHOMA USING 10-PROPARGYL-10-DEAZAAMINOPTERIN | |
| RU2012108144A (en) | ANTI-CANCER THERAPY DIRECTED AGAINST CANCER STEM CELLS AND CANCER FORMS RESISTANT TO TREATMENT BY MEDICINES | |
| JP2019529569A5 (en) | ||
| RU2007118237A (en) | METHOD FOR TREATING ALLERGIC DISEASES | |
| DE602004030048D1 (en) | EFFICIENCY | |
| RU2006134154A (en) | METHOD FOR THERAPY OF INDIVIDUAL DISORDERS IN THE BLOOD SYSTEM UNDER EXPERIMENTAL NEUROTIC INFLUENCES | |
| ATE495750T1 (en) | SULFATIDES FOR THE TREATMENT OF AUTOIMMUNE DISEASES | |
| MX2010006310A (en) | O-desmethyl-venlafaxine for treating major depressive disorder. | |
| MX2021007324A (en) | Oral therapy using 6,8-bis-benzylthio-octanoic acid. | |
| RU2013148539A (en) | ALISPORIVIR FOR TREATMENT OF HEPATITIS C VIRUS INFECTION | |
| RU2003124971A (en) | METHOD FOR TREATING PATIENTS WITH NEUROTIC AND SOMATOFORM DISORDERS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20080926 |